Chemical Immersion Coatings to Improve Biological Degradability of Magnesium Substrates for Potential Orthopaedic Applications
International Journal of Biomedical Materials Research
Volume 2, Issue 2, April 2014, Pages: 7-14
Received: Aug. 28, 2014; Accepted: Sep. 11, 2014; Published: Sep. 30, 2014
Views 2965      Downloads 202
Authors
Sridevi Brundavanam, Murdoch Applied Nanotechnology Research Group, Department of Physics, Energy Studies and Nanotechnology, School of Engineering and Energy, Murdoch University, Murdoch, Western Australia 6150, Australia
Gérrard Eddy Jai Poinern, Murdoch Applied Nanotechnology Research Group, Department of Physics, Energy Studies and Nanotechnology, School of Engineering and Energy, Murdoch University, Murdoch, Western Australia 6150, Australia
Derek Fawcett, Murdoch Applied Nanotechnology Research Group, Department of Physics, Energy Studies and Nanotechnology, School of Engineering and Energy, Murdoch University, Murdoch, Western Australia 6150, Australia
Article Tools
Follow on us
Abstract
Historically, cobalt-chromium, stainless steel and titanium alloys have been the main principal materials used in a variety of medical procedures for load-bearing implants in the body. Magnesium and magnesium-based alloys have the potential to be used as short-term structural support during the healing process of damaged hard tissues and diseased bone. Unlike traditional biologically compatible metals, which are not biologically degradable, magnesium based alloys offer both biological degradability and biological absorbability. Despite the many advantages offered by magnesium, its rapid degradation rate in the highly aggressive and corrosive body fluid environment has severely limited its present day medical application. This article reviews the chemical immersion technique for producing calcium phosphate coatings on magnesium substrates for slowing down the degradation rate while maintaining the biological compatibility and absorbability.
Keywords
Magnesium, Biodegradability, Chemical Immersion, Bone Tissue Engineering
To cite this article
Sridevi Brundavanam, Gérrard Eddy Jai Poinern, Derek Fawcett, Chemical Immersion Coatings to Improve Biological Degradability of Magnesium Substrates for Potential Orthopaedic Applications, International Journal of Biomedical Materials Research. Vol. 2, No. 2, 2014, pp. 7-14. doi: 10.11648/j.ijbmr.20140202.11
References
[1]
Lars L. The Bone and Joint Decade 2000-2010, Bull World Health Organ [online], 2003; 81: 629-629.
[2]
Park JB and Kim YK, Metallic Biomaterials, Biomaterials: Principles and Applications, ed. Park JB and Bronzino JD, (Boca Raton: CRC Press, 2003), 1-20.
[3]
Labek G, Thaler M, Janda W, Agreiter M, and Stockl B. Revision rates after total joint replacement: Cumulative results from worldwide joint register datasets. Journal of Bone & Joint Surgery, 2011; 93(B3): 293-297.
[4]
Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ, A Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue, Cell, 2006; 125(3): 577–591.
[5]
Dai NT, Williamson MR, Khammo N, Adams EF, Coombes AGA, Composite cell support membranes based on colla gen and polycaprolactone for tissue engineering of skin, Biomaterials, 2004; 25: 4263-4271.
[6]
Wang X, Du Y, Luo J, Lin B, Kennedy JF, Chitosan/organic rectorite nanocomposite films: Structure, characteristic and drug delivery behavior, Carbohydrate Polymers, 2007; 69: 41–49.
[7]
Dang JM, Leong KW, Natural polymers for gene delivery and tissue engineering, Advanced Drug Delivery Reviews, 2006; 58: 487– 499.
[8]
Halbleib M, Thomas S, Claudio de L, von Heimburgc D, Hauner H, Tissue engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in vitro differentia tion of human adipocyte precursor cells on scaffolds, Bio materials, 2003; 24: 3125–3132.
[9]
Kafedjiiski K, Jetti RKR, Florian F, Hoyer H, Werle M, Hoffer M, Bernkop-Schnurch A, Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery, International Journal of Pharmaceutics, 2007; 343(1-2): p.48–58.
[10]
Yang L, Li-Ming Z, Chemical structural and chain confor mational characterization of some bioactive polysaccharides isolated from natural sources, Carbohydrate polymers, 2009; 76(3): 349–361.
[11]
Kanazawa A, Suzuki M, Solid-state poly-condensation of natural aldopentoses and 6- deoxyaldohexoses. Facile preparation of highly branched polysaccharide, Polymer, 2006; 47(1): 176–183.
[12]
Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, Messmer BJ, Turina M, Fibrin gel – ad vantages of a new scaffold in cardiovascular tissue engi neering, European Journal of Cardio-thoracic Surgery, 2011;.19: 424-430.
[13]
Ryan EA, Mockros LF, Stern AM, Lorand L, Influence of a Natural and a Synthetic Inhibitor of Factor XIIIa on Fibrin Clot Rheology, Biophysical Journal, 1999; 77: 2827–2836.
[14]
Kanczler JM, Ginty PJ, Barry JJA, Clarke NMP, Howdle SM, Shakesheff KM, Oreffo ROC, The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials. 2008; 29: 1892-1900.
[15]
Rimondini L, Nicoli-Aldini N, Fini M, Guzzardella G, Tschon M, Giardino R, In vivo experimental study on bone regeneration in critical bone defects using an injectable bio degradable PLA/PGA copolymer. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2005; 99: 148-54.
[16]
Wang Z, Wang S, Marois Y, Guidoin R, Zhang Z, Evaluation of biodegradable synthetic scaffold coated on arterial pros theses implanted in rat subcutaneous tissue. Biomaterials, 2005; 26: 7387–7401.
[17]
Sato T, Chen G, Ushida T, Ishii T, Ochiai N, Tateishi T, Ta naka J, Evaluation of PLLA–collagen hybrid sponge as a scaffold for cartilage tissue engineering. J. M Sec. 2004; C24: 365–372.
[18]
Qiao M, Chen D, Ma X, Liu Y, Inject-able biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: Synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels. Int. J. Pharm. 2005; 294: 103–112.
[19]
Lee JJ, Lee SG, Park JC, Yang YI, Kim JK, Investigation on biodegradable PLGA scaffold with various pore size structure for skin tissue engineering. J. Current. App. Phys. 2007; 7S1: e37–e40.
[20]
Todo M, Park SD, Takayama T, Arakawa K, Fracture mi cro-mechanisms of bio-absorbable PLLA/PCL polymer blends., J. Eng. Frac. Mech, 2007; 4: 1872–1883.
[21]
Rezgui F, Swistek M, Hiver JM, G’Sell C, Sadoun T, De formation and damage upon stretching of degradable poly mers (PLA and PCL). J. Polymer, 2005; 46: 7370–7385.
[22]
Wang YC, Lin MC, Wang DM, Hsieh HJ, Fabrication of a novel porous PGA-chitosan hybrid matrix for tissue engi neering. Biomaterials, 2003; 24: 1047–1057.
[23]
Hsieh CY, Tsai SP, Wang DM, Chang YN, Hsieh HJ, Prepa ration of g-PGA/chitosan composite tissue engineering ma trices. Biomaterials, 2005; 26: 5617–5623.
[24]
Kreuter J: Nanoparticulate systems for brain delivery of drugs. Adv. Drug Del. Rev. 2001; 47: 65-81.
[25]
Han ML, Lowman AM, Biodegradable nanoparticles for drug delivery and targeting. Current Opinions Solid State Mat. 2002; 6: 319-327.
[26]
Blaker JJ, Knowles JC, Day RM, Novel fabrication tech niques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery. Acta Biomaterialia.2008; 4: 264-272.
[27]
Lyu SP, Untereker D, Degradability of polymers for im plantable biomedical devices. Int. J Mol Sci Sep, 2009; 10(9): 4033-4065.
[28]
Le X, Poinern GEJ, Ali N, Berry CM and Fawcett D, Engi neering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. International Journal of Biomaterials 2013; Article ID 782549:16 pages.
[29]
Long M and Rack HJ, Titanium alloys in total joint re placement – a materials science perspective. Biomaterials, 1998; 19: 1621-1639.
[30]
Dearnly PA, A brief review of test methodologies for sur face-engineered biomedical implant alloys, Surface and Coatings Technology, 2005; 198(1-3): 483-490.
[31]
Geetha M, Singh AK, Asokamani R, Gogia AK, Ti based biomaterials, the ultimate choice for orthopaedic implants – A review, Progress in Materials Science, 2009; 54: 397–425.
[32]
Hallab N, Merritt K, Jacobs JJ, Metal Sensitivity in Patients with Orthopaedic Implants, J. Bone Joint Surg. Am., 2001; 83: 428-428.
[33]
Lhotka C, Szekeres T, Steffan I, Zhuber K, Zweymuller K. Four-year study of cobalt and chromium blood levels in patients managed with two different metal-on-metal total hip replacements. Journal of Orthopedic Research, 2003; 21(2): 189-195.
[34]
Haynes DR, Boyle SJ, Rogers SD, Howie DW, Vernon-Robert B, Variation in cytokines induced by patients from different prosthetic materials, Clinical Orthopaedics and Related Research, 1998; 352: 323-230.
[35]
Li Y, Yang C, Zhao H, Qu S, Li X, Li Y, New developments of Ti-based alloys for biomedical applications. Materials, 2014; 7: 1709-1800.
[36]
Nagels J, Stokdijk M, Rozing PM, Stress shielding and bone resorportion in shoulder arthroplasty, Journal of Shoulder and Elbow Surgery, 2003; 12(1): 35-39.
[37]
Polmear IJ, Magnesium alloys and applications, Materials Science and Technology, 1994; 10(1): 1-16.
[38]
Razavi M, Fathi MH, Meratian M et al. Microstructure, mechanical properties and biocorrosion evaluation of bio degradable AZ91-FA nanocomposites for biomedical appli cations, Materials Science and Engineering A, 2010; 527(26): 6938-6944.
[39]
Feng A, Han Y, The microstructure, mechanical and corro sion properties of calcium phosphate reinforced ZK60A magnesium alloy composites, Journal of Alloys and Compounds, 2010; 504: 585-593.
[40]
Saris NL, Mervaala E, Karppanen H, Khawaja JA, Lewen stam A, Magnesium. An update on physiological, clinical and analytical aspects, Clinica Chimica Acta, 2009; 294: 1-26.
[41]
Kim SR, Lee JH, Kim YT, Riu DH, Jung SJ, Lee YJ, Chung SC, Kim YH, Synthesis of Si, Mg substituted hydroxyap atites and their sintering behaviours, Biomaterials, 2003; 24(8): 1389-1398.
[42]
Robinson AD, Griffith RW, Shechtman D, Evans RB, Con zemius MG, In vivo antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus, Acta Biomaterialia, 2010; 6: 1869- 1877.
[43]
Poinern GEJ, Brundavanam S, Fawcett D, Biomedical Magnesium Alloys: A Review of Material Properties, Sur face Modifications and Potential as a Biodegradable Ortho paedic Implant, American Journal of Biomedical Engineer ing 2012; 2(6): 218- 240.
[44]
Shaw BA, Corrosion resistance of magnesium alloys. In: Ed: Stephens D. ASM handbook, Vol 13a: corrosion fundamen tals, testing and protection. UK: ASM Int.; 2003.
[45]
Fekry AM, Ameerm MA, Electrochemistry and impedance studies on titanium and magnesium alloys in Ringer’s solu tion, International Journal of Electrochemical Science, 2011; 6: 1342-1354.
[46]
Witte F, Kaese V, Haferkamp H, Switzer E, Mey er-Lindenberg A, Wirth CJ, Windhagen H, In vivo corro sion of magnesium alloys and the associated bone response, Biomaterials, 2005; 26(17): 3557-3563.
[47]
Song G, Control of biodegradation of biocompatible magne sium alloys, Corrosion Science, 2007; 49(4): 1696-1701.
[48]
Zeng RC, Zhang J, Huang WJ, Dietzel W, Kainer KU, Blawert C, et al. Review of studies on corrosion of magne sium alloys. Transactions of Nonferrous Metals Society of China, 2006; 16(Supplement 2): s763-s771.
[49]
Song G, Atrens A. Understanding Magnesium Corrosion: Framework for Improved Alloy Performance. Advanced Engineering Materials, 2003; 5(12): 837-858.
[50]
Wang H, Shi ZM. In vitro biodegradation behaviour of magnesium and magnesium alloys. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2011; 98 B (2): 203-209.
[51]
Roy R and Lee K. Biomedical application of diamond-like carbon coatings: A review. J Biomed Mater Res Part B Appl Biomater, 2007; 83: 72–84.
[52]
Gray JE, Luan B, Protective coatings on magnesium and its alloys – a critical review, Journal of Alloys and Compounds, 2002; 336(1): 88-113.
[53]
Wang J, Tang J, Zhang P, Li Y, Lai Y, Qin L. Surface modi fications of magnesium alloys developed for bioabsorbable orthopaedic implants: A general review. J Biomed Mater Res Part B Appl Biomater 2012; 100B: 1691–1701.
[54]
Hornberger H, Virtanen S, Boccaccini A. Biomedical coat ings on magnesium alloys—A review. Acta Biomater 2012; 8: 2442–2455.
[55]
Cui FZ, Yang JX, Jiao YP, Lee IS, Yin QS, Zhang Y. Modi fication of degradation behaviour of magnesium alloy by IBAD coating of calcium phosphate. Surface & Coatings Technology, 2008; 202(22-23): 5733-5736.
[56]
Wang Y, Wei M, Gao J, Improve corrosion resistance of magnesium in simulated body fluid by dicalcium phosphate dihydrate coating, Materials Science and Engineering: C, 2009; 29: 1311-1316.
[57]
Jo JH, Kang BG, Shin KS, et al. Hydroxyapatite coating on magnesium with MgF(2) interlayer for enhanced corrosion resistance and biocompatibility. J Mater Sci Mater. Med, 2011; 22: 2437–2447.
[58]
Wang H, Guan S, Wang Y, et al. In vivo degradation behavior of Ca-deficient hydroxyapatite coated Mg-Zn-Ca alloy for bone implant application. Colloids Surf B. Biointerfaces, 2011; 88: 254–29.
[59]
Yang JX, Cui FZ, Lee I-S, et al. In vivo biocompatibility and degradation behavior of Mg alloy coated by calcium phos phate in a rabbit model. J. Biomater. Appl., 2012; 27: 153–164.
[60]
Poinern GEJ, Brundavanam R, Le X, Nicholls PK, Cake MA, Fawcett D. The synthesis, characterisation and in vivo study of a bioceramic for potential tissue regeneration ap plications, Scientific Reports, 2014; 4, 6235: 1-9.
[61]
Virtanen S, Keim S, Brunner JG, Fabry B. Control of mag nesium corrosion and biocompatibility with biomimetic coatings. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2011 96(1): 84-90.
[62]
Yang JX, Cui FZ, Lee IS, et al. In vivo biocompatibility and degradation behaviour of Mg alloy coated by calcium phosphate in a rabbit model, Journal of Biomaterials Appli cations 2012; 27(2): 153-1643.
[63]
Hiromoto S, Tomozawa M. Growth mechanism of hy droxyapatite-coatings formed on pure magnesium and corrosion behavior of the coated magnesium. Applied Sur face Science 2011; 257(19): 8253-8257.
[64]
Xu L, Zhang E, Yang K, Phosphating treatment and corrosion properties of Mg–Mn– Zn alloy for biomedical application, Journal of Materials Science: Materials in Medicine, 2009; 20: 859–867.
[65]
Xu L, Pan F, Yu G, et al. In vitro and in vivo evaluation of the surface bioactivity of a calcium phosphate coated mag nesium alloy, Biomaterials, 2009; 30: 1512–1523.
[66]
Yanovska A, Kuznetsov V, Stanislavov A, Danilchenko S, Sukhodub L, Calcium phosphate coatings obtained biomimetically on magnesium substrates under low magnetic fields, Applied Surface Science, 2012; 258: 8577–8584.
[67]
Poinern GJE, Brundavanam R, Le X, Djordjevic S, Prokic M, Fawcett D, Thermal and ultrasonic influence in the formation of nanometer scale hydroxyapatite bio-ceramic. International Journal of Nanomedicine 2011:6 2083–2095.
[68]
Blom A. Which scaffold for which application? Curr Ortho paed. 2007; 21(4): 280–287.
[69]
Habibovic P, de Groot K. Osteoinductive biomaterials prop erties and relevance in bone repair. J Tissue Eng and Regen Med. 2007; 1(1): 25–32.
[70]
Kalita SJ, Bhardwaj A, Bhatt HA. Nanocrystalline calcium phosphate ceramics in biomedical engineering. Materials Science and Engineering C. 2007; 27(3): 441–449.
[71]
Taniguchi M, Takeyema H, Mizunna I, et al. The clinical application of intravenous catheter with percutaneous device made of sintered hydroxyapatite. Japanese J Artificial Organs. 1991; 20(2): 460–464.
[72]
Hutmacher DW, Schantz JT, Lam CXF, Tan KC, Lim TC. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J. Tissue Eng Regen Med. 2007; 1: 245–260.
[73]
Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineer ing. Adv Drug Deliver Rev. 2007; 59(4–5): 234–248.
[74]
Silva RV, Camilli JA, Bertran JA, Moreira NH. The use of hydroxyapatite and autogenous cancellous bone grafts to repair bone defects in rats. Inter J Oral Maxillofacial Surg. 2005; 34(2): 178–184.
[75]
Stoch A, Jastrzebski W, Dlugon E, et al. Sol-gel derived hydroxapatite coatings on titanium and its alloy Ti6 Al4V. J Mol. Struct. 2005; 744–747: 633–640.
[76]
Vecchio KS, Zhang X, Massie JB, Wang M, Kim CW. Con version of bulk seashells to biocompatiable hydroxyapatite for bone implants. Acta Biomater. 2007; 3(6): 910–918.
[77]
Tomozawa M, Sachiko Hiromoto S, Yoshitomo Harada Y, Microstructure of hydroxyapatite-coated magnesium pre pared in aqueous solution. Surface & Coatings Technology 2010; 204: 3243–3247.
[78]
Diamant RME, Applied Chemical Chemistry for Engineers, Pitman Publishing, 1972, Chap 5.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186